News and Events
The MCG system is the most accurate means for non-invasive detection of heart disease currently available.
2010 News
February 2010 Newsletter
Women's Heart Foundation Newsletter
-
Beginning with National Wear Red Day® Friday, February 5, 2010, millions of people helped spread the word that heart disease is women's #1 killer.
Please see the press release for additional information.
February 13, 2010
Leadership in Science and Medicine
-
Dr. Joseph T. Shen was recognized with the Women’s Heart Advocate Award for his Leadership in Science and Medicine. "Dr. Shen’s invention of the Multifunction CardioGram represents a major breakthrough in cardiology" said Bonnie Arkus.
Please see the press release for additional information.
February 11, 2010
The Women’s Heart Foundation presents the Women’s Heart Advocate Award for Medicine and Science to Multifunction CardioGram™ Inventor Dr. Joseph T. Shen
-
Port Washington, NY - February 11, 2010: Premier Heart, LLC proudly announces that the Women’s Heart Foundation will honor Joseph T. Shen, M.D., the inventor of the Multifunction CardioGram™ (MCG™) with its Medical and Science Achievement Award.
Please see the press release for additional information.
2009 News
September 30, 2009
Premier Heart announces availability of MCG in Latin America and the Caribbean
-
Premier Heart, LLC today announced the formation of Premier Heart CICA, a new division to launch its Multifunction Cardiogram™ (MCG), system in Latin America and the Caribbean.
Please see the press release for additional information.
July 13, 2009
Premier Heart announces availability of MCG
-
Premier Heart is pleased to announce the availability of the Multifunction Cardiogram (MCG™), the evolution of our groundbreaking 3DMP technology. MCG delivers unparalleled diagnostic accuracy through a non-invasive pain, stress, and radiation-free test.
Please see the press release for additional information.
July 2, 2009
AMA releases Category III CPT code for MCG
-
Premier Heart is pleased to announce the release of our Category III CPT code in the July 2009 CPT update. This code will be used for insurance reporting and reimbursement as well as tracking adoption of MCG to substantiate "widespread use" for our Category I code application.
MCG has been assigned the coding identifier 0206T, which will be implemented for use beginning January 1, 2010. For more information please see the AMA's Category III Code information at http://www.ama-assn.org/ama1/pub/upload/mm/362/cptcat3codes.pdf.
Premier Heart has issued a formal press release on the availability of MCG and our new CPT code.
Please see the press release for additional information.
May 1, 2009
Clinical Trial Meta-Analysis Published
-
Premier Heart is pleased to announce the publication of our clinical trial meta-analysis, compiling data from our peer-reviewed studies conducted at leading heart centers around the world.
The meta-analysis article has been published in the April edition of the International Journal of Medical Sciences, and is available in the Clinical Trials section of our website, or via this direct link.
January 26, 2009
Premier Heart Japan Launched
-
The Premier Heart International Sales team is pleased to
announce the official launch of Premier Heart Japan, our full-service division
handling the Asia-Pacific region.
We are currently seeking regulatory approval for clinical use in Japan, however the Premier Heart Japan team will begin distributing units to The Philippines later this year.